Final Program - Canadian Society of Hospital Pharmacists

western branches
british columbia
alberta
saskatchewan
manitoba

Welcome to the 39th Annual CSHP Western Branches Banff Seminar. In 2013, our theme is The Art
of Pharmacy Practice which we hope will provide you some new and unique inspiration as you
practice the science, and the art, of pharmacy.
The Banff Seminar Planning Committee is a group of volunteers that work throughout the year to
organize this excellent conference. I would like to take the opportunity to thank them all for their
time and effort they have committed towards planning speakers, activities, and other logistics of
this conference. Please thank them if you get the chance! They’ll be easily recognizable around the
Banff Centre throughout the weekend.
Our committee would also like to give a big thank you to our industry sponsors who provide
us with funding to offset some of the conference expenses. Their sponsorship ensures that our
registration fees remain affordable for pharmacy technicians, pharmacists, students and others to
attend the conference.
We also would like to thank the speakers who have committed their time and expertise to prepare
current topics and their time to travel to Banff this weekend.
Lastly, and most importantly, we would like to thank you! Without your ongoing support and
attendance, this conference would not be possible. I hope that you enjoy the educational
components and networking opportunities throughout the weekend and get the chance to enjoy
this beautiful town and national park we are in.
Enjoy the weekend!
Esther Jadusingh
CHAIRPERSON
CSHP WESTERN BRANCHES BANFF SEMINAR PLANNING COMMITTEE
WELCOME

PROGRAM OUTLINE
FRIDAY, MARCH 22, 2013
1100-1700
Registration Desk Opens
1300-1315
Opening Remarks
1315-1330
60 second poster fame part 1
1330-1415
Anticoagulation in Renal Impairment – A Rock and a
Hard Place
Patients with renal dysfunction have signifi cant
physiologic changes that can predispose them to
bleeding complications. While the advent of the new
oral anticoagulants provides clinicians with alternatives
for patients, many outstanding issues remain, including
appropriate patient selection and management strategies
for bleeding. This presentation will review the challenges
and strategies for managing anticoagulation in patients
with renal impairment.
CYNTHIA BROCKLEBANK, BScPharm, PharmD, ACPR,
CDE, Clinical Pharmacist, Chronic Disease Management,
Alberta Health Services, Calgary, Alberta
1415-1500
Introduction to Rhythm Interpretation
This will be an highly informative and interactive session
on the basics of cardiac rhythms and 12 Lead ECG
interpretation. The goals of this talk will be to understand
the essentials of rhythm interpretation and to explore 12
Lead ECG fundamentals.
CHRIS COLTMAN, RN, BScN, Clinical Nurse Educator,
CVICU Unit 94, Foothills Medical Centre, Alberta Health
Services, Calgary, Alberta
1500-1515
60 second poster fame part 2
1515-1545
BREAK
1545-1645
CONCURRENT SESSIONS
1. Prevention of Mother to Child Transmission of HIV
– How LOW Can We Go?
This presentation will provide pharmacists with an overview
of the epidemiology of mother-to-child transmission
(MTCT) of HIV, as well as risk factors for transmission.
Recommendations from current guidelines regarding
strategies to prevent MTCT of HIV will be reviewed, as well
as results from local research. Participants will develop an
understanding of the role of the pharmacist in perinatal
management of HIV disease.
CHRISTINE HUGHES, BScPharm, PharmD, FCSHP, AAHIVP,
Clinical Pharmacotherapy Practitioner, HIV, Northern Alberta
HIV, Program, Alberta Health Services, Edmonton, Alberta
2. Tackling COPD Stagnation – Moving Through Old
Guidelines to Apply New Evidence to Your Patient
In this session, through the application of new evidence
and perspectives, we will build upon basics in COPD
management in order to help progress towards more
effective patient-centred care. With a basis of wellfounded
therapeutic outcomes, a primary focus will be
to delve into the evidence supporting currently available
pharmacotherapeutic options such that we can determine
how best to translate potential benefi ts and harms not
only to ourselves, but also to translate this information
into something meaningful to patients. We will also look
briefl y at the management of acute exacerbations in the
community and hospital settings. The essential role of
the pharmacist as an advisor, educator, and advocate to
patients and providers will be prominent throughout the
session.
JAMIE FALK, BScPharm, PharmD, Clinical Pharmacist,
Family Medicine and Primary Care, Kildonan Medical Centre,
WRHA, Clinical Assistant Professor, Faculties of Medicine and
Pharmacy, University of Manitoba, Winnipeg, Manitoba
1900
OPENING RECEPTION
“Hawaiian Luau – Hawaiian Theme Night!”
You are invited to join us for a fun night at a Hawaiian Luau.
Dress up in your favorite Hawaiian/tropical outfi t (that’s right,
get out your leis, tropical shirts, grass skirts…)! There will be
food and drinks plus plenty of friendly competition and theme
activities courtesy of CSHP BC Branch. Prizes will be awarded
for the competition/theme activities and also for the best
Hawaiian outfi t. So shake those hips and sway to the music as
we party it up Hawaiian style!
DAY 1

PROGRAM OUTLINE
SATURDAY, MARCH 23, 2013
800-1200
Registration Desk Opens
Exhibits Open
815-830
Opening Remarks
830-945
KEYNOTE
Mea Culpa: A Health Professional’s Personal Reflection
on Medical Errors
As many as 24,000 Canadians die every year at Canadian
hospitals due to preventable medical errors. In the
United States, it is currently estimated that as many as
200,000 Americans die each year of preventable medical
errors. One of the most important causes of preventable
errors relate to medications. There is a signifi cant
medical error in roughly one in ten medications given to
hospitalized patients. The errors reported include wrong
drug, wrong dosage and wrong route of administration.
Other causes of medical error include transfusion
reactions, wrong side surgery and hospital acquired
infections. This presentation will discuss common errors
and factors that contribute to errors such as fatigue and
sleep deprivation. The culture of modern medicine tends
to make health professionals experience a deep sense
of shame as a result of making mistakes. That leads
to denial and rationalization of mistakes, which makes
it diffi cult to learn from them and to teach others how
to avoid them. Using audio clips from his radio show
White Coat Black Art as well as his own experience
making mistakes, Dr. Goldman will discuss the roots of
medical errors and how to create a culture of safety by
reducing unhealthy shame and by creating a framework
in which errors can be discussed more constructively.
The presentation will highlight the pharmacist errors and
where possible present this subject from the pharmacist
point of view.
DR. BRIAN GOLDMAN MD, Emergency Physician,
Broadcaster and Medical Watchdog with a Passion for
Compassion, Toronto, Ontario
945-1015
Break
1015-1055
Hyponatremia – Busting Myths and de-Mist-ifying its
Assessment & Management
Hyponatremia is the most common electrolyte derangement
among hospitalized patients. Understanding why it occurs
and how to manage it is far more complicated than other
electrolyte disturbances because it is intimately linked to
our understanding of body water, which is also a complex
system. Because of the many connections between
hyponatremia, hypovolemia, and drug therapies like
diuretics, ACE-Inhibitors/ARBs, drug-related causes of SIADH
(and drug treatments for it), and others, it is important for
pharmacists to have a solid approach to hyponatremia
and related disorders. In this session, we will sketch an
approach to hyponatremia assessment and management,
provide a basis and pathway for further learning about it,
and bust several myths about sodium and water along the
way.
PETER LOEWEN, BScPharm, ACPR, PharmD, FCSHP,
Director, Doctor of Pharmacy Programs, Assistant Professor,
Faculty of Pharmaceutical Sciences The University of British
Columbia, Vancouver, British Columbia
1055-1135
New Therapies for Type 2 Diabetes – What Do We Do
With Them??
Over the last few years, there have been new therapies
introduced for the treatment of Type 2 diabetes, including
the GLP receptor antagonists and the DPP-4 inhibitors. The
2008 Clinical Practice Guidelines offered little guidance for
when these therapies should be used, but what will the
2013 guidelines tell us? In addition, this presentation will
highlight some of the therapies currently in development for
the treatment of Type 2 diabetes.
RHONDA ROEDLER, BScPharm, ACPR, PharmD, CDE,
Clinical Practice Leader, Foothills Medical Centre, Alberta
Health Services, Calgary, Alberta
1135-1205
BREAK
DAY 2

SATURDAY, MARCH 23, 2013…CONTINUED
1205-1250
CONCURRENT SESSION
1. The Art and Evidence for Sedation of Adult
Intensive Care Patients
Sedation of intensive care patients is often necessary for
medical and physiological reasons, and to ensure patient
safety and comfort. Multiple classes of medications are
often combined to achieve sedation goals as no one
agent has comprehensive and optimal effects on its
own.
During this presentation, we will describe the
pharmacology of the agents currently available,
including dexmedetomidine as the newest addition to
our therapeutic options. We will review the most current
up to date evidence-based sedation practices and
guidelines, and fi nally discuss the art of applying them to
direct patient care.
JERROLD PERROTT, BScPharm, ACPR, PharmD, Clinical
Pharmacy Specialist, Critical Care, Royal Columbian
Hospital, Lower Mainland Pharmacy Services, New
Westminster, British Columbia
2. Oncology Update
CARLO DE ANGELIS, PharmD, Clinician Scientist –
Oncology Pharmacy, Department of Pharmacy, Bayview
Campus, Sunnybrook Health Sciences Centre
Toronto, ON
1900
BANQUET
DAY 2

PROGRAM OUTLINE
SUNDAY, MARCH 24, 2013
800-1100
Registration Desk Opens
Vendor Exhibits Opens
815-855
It’s Not Easy Being Short
A brief history of how we found ourselves in the midst
of the shortages will be outlined. Specifi cally relating to
Saskatchewan, coping strategies that have been used will be
described and potential coping strategies explored. Also to be
deliberated the questions: Has anything positive arisen from the
shortages? What are our next steps
CARMEN BELL, BSP, Drug Information Consultant,
Saskatchewan Drug Information Service, College of Pharmacy
& Nutrition, University of Saskatchewan, Saskatoon,
Saskatchewan
900-1000
CONCURRENT SESSIONS
1. Delirium in the Elderly
Delirium is a common condition in the elderly. It is
associated with serious adverse outcomes. Delirium is
often not identifi ed or misdiagnosed as another psychiatric
condition such as depression or dementia. This presentation
will describe the clinical presentation of delirium, identify
the different etiologies of delirium and outline an approach
to the prevention and management of delirium.
MARLA DAVIDSON, MD, Department of Psychiatry, University
of Saskatchewan, Saskatoon, Saskatchewan
2. Experiential Training for Pharmacy Students: Time
for Change
In almost all provincial jurisdictions, legislative changes are
occurring that permit pharmacists to expand their scope of
practice by assuming greater responsibility for managing
drug therapy. These expanded roles include a variety of
patient-centred activities such as adapting and initiating
drug therapy. However , patient-centred care requires a
different set of skills (e.g. clinical practice skills, critical
thinking skills, decision-making skills under conditions
of uncertainty, collaborative interpersonal practice skills)
than those that were needed to be a good pharmacist in
the past (e.g. attention to detail, accuracy, risk-aversion).
Many of the skills that pharmacists will need to succeed
in the practice models of the future are best learned in
experiential practice settings where students gradually
assume greater and greater responsibility and accountability
for the development of drug therapy treatment plans
and their associated outcomes. Unfortunately, many of
the experiential training models that exist across the
country could best be described as “observerships”, in
which students are accompanied by a preceptor at all
times and in which there is not an expectation that the
student will play an active role in the delivery of care.
This presentation will explore the options that exist for
new experiential models that offer a greater potential
to produce pharmacy graduates who are both able and
willing to accept responsibility and accountability for
drug therapy management.
KEVIN W. HALL, BScPharm, PharmD, FCSHP,
Clinical Associate Professor, Faculty of Pharmacy and
Pharmaceutical Sciences, University of Alberta, Edmonton,
Alberta
1000-1030
BREAK
1030-1130
Procedural Sedation in the Pediatric Emergency
Department.
Procedural sedation is a central aspect of the practice of
a pediatric emergency physician. The body of literature on
this topic has greatly expanded in the last half-decade. This
presentation will be a case-based review of new evidence
available to the emergency medicine physician in order
to perform procedural sedation in children safely and
effectively. The pharmacology/pharmacokinetics, indications
and safety profi les of various agents will be reviewed.
RAPHAEL PAQUIN, MD, FRCPC, Pediatric Emergency
Medicine, Montreal Children’s Hospital, Montreal, Quebec
1130-1230
The Art of Managing the Poisoned Patient: An Admixture
of Toxins, Antidotes and Pharmacists
A review of common drug overdoses and poisonings such
as acetaminophen, salicylates, cardiac glycosides and
toxic alcohols will be provided. The role of the hospital
pharmacist in the management of poisoned patients will
be highlighted with a focus on common therapeutic issues
faced by poison centres. The use of novel antidotal therapies
such as lipid emulsion therapy will also be examined.
AMIN RAJWANI, BSc, BScPharm, MSW, RSW, CSPI,
PADIS: Poison and Drug Information, Service (Alberta/
Saskatchewan/NWT), Calgary, Alberta
1230-1245
CLOSING REMARKS
DAY 3

MAJOR BENEFACTORS
BENEFACTORS
SPONSORS
Abbott
AmerisourceBergen
Apotex
BioSyent
BMS-Pfizer
Boehringer-Ingleheim
Canadian Forces
Interior Health Authority
Leo Pharma Inc.
LexiComp
McKesson
Omega
Paladin Labs
Pendopharm
Sandoz
Sunovion Pharmaceuticals
Canada
SwissLog
DONATIONS